Related Experiment Video
Updated: Dec 25, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Coronary endothelial dysfunction prevented by small-conductance calcium-activated potassium channel activator in mice
Zhiqi Zhang1, Guangbin Shi1, Yuhong Liu1
1Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI.
Objective:
To investigate coronary endothelial protection of a small-conductance calcium-activated potassium (SK) channel activator against a period of cardioplegic-hypoxia and reoxygenation (CP-H/R) injury in mice and patients with diabetes (DM) and those without diabetes (nondiabetic [ND]).
Methods:
Mouse small coronary arteries/heart endothelial cells (MHECs) and human coronary arterial endothelial cells (HCAECs) were dissected from the harvested hearts of mice (n = 16/group) and from discarded right atrial tissue samples of patients with DM and without DM (n = 8/group). The SK current density of MHECs was measured. The in vitro small arteries/arterioles, MHECs, and HCAECs were subjected to 60 minutes of CP hypoxia, followed by 60 minutes of oxygenation. Vessels were treated with or without the selective SK activator NS309 for 5 minutes before and during CP hypoxia.
Results:
DM and/or CP-H/R significantly inhibited the total SK currents of MHECs and HCAECs and significantly diminished the mouse coronary relaxation response to NS309. Administration of NS309 immediately before and during CP hypoxia significantly improved the recovery of coronary endothelial function, as demonstrated by increased relaxation responses to adenosine 5'-diphosphate and substance P compared with those seen in controls (P < .05). This protective effect was more pronounced in vessels from ND mice and patients compared with DM mice and patients (P < .05). Cell surface membrane SK3 expression was significantly reduced after hypoxia, whereas cytosolic SK3 expression was greater than that of the sham control group (P < .05).
Conclusions:
Application of NS309 immediately before and during CP hypoxia protects mouse and human coronary microvasculature against CP-H/R injury, but this effect is diminished in the diabetic coronary microvasculature. SK inhibition/inactivation and/or internalization/redistribution may contribute to CP-H/R-induced coronary endothelial and vascular relaxation dysfunction.
Insights
A small-conductance calcium-activated potassium (SK) channel activator, NS309, protects coronary microvasculature from cardioplegic-hypoxia and reoxygenation (CP-H/R) injury. However, this protective effect is reduced in diabetic patients and mice.
Area of Science:
- Cardiovascular Science
- Endothelial Biology
- Potassium Channel Function
Background:
- Coronary microvascular dysfunction is a significant complication following cardiac procedures.
- Small-conductance calcium-activated potassium (SK) channels play a role in regulating vascular tone and endothelial function.
- Diabetes mellitus exacerbates cardiovascular injury and impairs endothelial function.
Purpose of the Study:
- To evaluate the protective effects of an SK channel activator against cardioplegic-hypoxia and reoxygenation (CP-H/R) injury.
- To compare the efficacy of SK channel activation in diabetic versus nondiabetic subjects.
- To investigate the impact of CP-H/R on SK channel function and expression in the coronary microvasculature.
Main Methods:
- Mouse and human coronary endothelial cells and small arteries were isolated.
- Cells and vessels were subjected to in vitro CP-H/R injury.
- Treatment with the selective SK channel activator NS309 was administered before and during CP-H/R.
- SK current density, coronary relaxation, and SK3 channel expression were measured.
Main Results:
- CP-H/R injury significantly reduced SK current density and coronary relaxation responses.
- NS309 treatment significantly improved endothelial function recovery after CP-H/R.
- The protective effect of NS309 was more pronounced in nondiabetic subjects compared to diabetic subjects.
- Hypoxia led to reduced cell surface SK3 expression and increased cytosolic SK3 expression.
Conclusions:
- The SK channel activator NS309 demonstrates protective effects on the coronary microvasculature against CP-H/R injury.
- Diabetic coronary microvasculature exhibits a diminished response to NS309-mediated protection.
- SK channel dysfunction, including altered expression and localization, may contribute to CP-H/R-induced vascular dysfunction in diabetes.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Antihypertensive Drugs: Action of Calcium Channel Blockers
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Antihypertensive Drugs: Vasodilators
Coronary Artery Disease V: Interprofessional Care

